Triptolide induces apoptosis of gastric cancer cells via inhibiting the overexpression of MDM2

Medical Oncology

Volumn 31, Issue 11, 2014, Pages 1-7

  Wang, Bo Yong ^a   Cao, Jun ^a   Chen, Ji Wei ^a   Liu, Quan Yan ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Gastric cancer; MDM2; p53 protein; Triptolide

Indexed keywords

PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PUMA PROTEIN; TRIPTOLIDE; X LINKED INHIBITOR OF APOPTOSIS; ALKYLATING AGENT; DITERPENE; EPOXIDE; MDM2 PROTEIN, HUMAN; PHENANTHRENE DERIVATIVE; TUMOR MARKER;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PATIENT; CHRONIC GASTRITIS; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; STOMACH; STOMACH BIOPSY; STOMACH CANCER; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; STOMACH NEOPLASMS; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHENANTHRENES; PROTO-ONCOGENE PROTEINS C-MDM2; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84919924742     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0270-7     Document Type: Article

References (23)

1. Bollschweiler E, Berlth F, Baltin C, et al. Treatment of early gastric cancer in the Western World. World J Gastroenterol. 2014;20:5672–8.
2. Asombang AW, Rahman R, Ibdah JA. Gastric cancer in Africa: current management and outcomes. World J Gastroenterol. 2014;20:3875–9.
3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
4. Camargo MC, Anderson WF, King JB, et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 2011;60:1644–9.
5. Proserpio I, Rausei S, Barzaghi S, et al. Multimodal treatment of gastric cancer. World J Gastrointest Surg. 2014;6:55–8.
6. Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997;420:25–7.
7. Eischen CM, Lozano G. p53 and MDM2: antagonists or partners in crime? Cancer Cell. 2009;15:161–2.
8. Nakajima N, Ito Y, Yokoyama K, et al. The expression of murine double minute 2 (MDM2) on Helicobacter pylori-infected intestinal metaplasia and gastric cancer. J Clin Biochem Nutr. 2009;44:196–202.
9. Vazquez A, Bond EE, Levine AJ, et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov. 2008;7:979–87.
10. Shangary S, Wang S. Small-molecule inhibitors of the MDM2–p53 protein–protein interaction to reactivate p53 function: a novel approach for cancer therapy. Annu Rev Pharmacol Toxicol. 2009;49:223–41.
11. Huang M, Zhang H, Liu T, et al. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway. Mol Cancer Ther. 2013;12:184–94.
12. Wang W, Yang S, Su Y, et al. Enhanced antitumor effect of combined triptolide and ionizing radiation. Clin Cancer Res. 2007;13:4891–9.
13. Mujumdar N, Mackenzie TN, Dudeja V, et al. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. Gastroenterology. 2010;139:598–608.
14. Kitzen JJ, de Jonge MJ, Lamers CH, et al. Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours. Eur J Cancer. 2009;45:1764–72.
15. Zhu W, Ou Y, Li Y, et al. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol. 2009;75:812–9.
16. Phillips PA, Dudeja V, McCarroll JA, et al. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res. 2007;67:9407–16.
17. Chen G, Sordillo EM, Ramey WG, et al. Apoptosis in gastric epithelial cells induced by Helicobacter pylori and accompanied by increased expression of BAK. Biochem Biophys Res Commun. 1997;239:626–32.
18. Teodoro JG, Evans SK, Green MR. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med (Berl). 2007;85:1175–86.
19. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene. 2003;22:9030–40.
20. Shangary S, Wang S. Targeting the MDM2–p53 interaction for cancer therapy. Clin Cancer Res. 2008;14:5318–24.
21. Chang WT, Kang JJ, Lee KY, et al. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J Biol Chem. 2001;276:2221–7.
22. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006;7:988–94.
23. Wang DG, Sun YB, Ye F, et al. Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells. Mol Cell Biochem. 2014;386:143–52.